Due to the COVID-19 pandemic, the global Viibryd (Vilazodone) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.
Fully considering the economic change by this health crisis, 10 mg accounting for % of the Viibryd (Vilazodone) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.
While Major Depression segment is altered to an % CAGR throughout this forecast period.
China Viibryd (Vilazodone) market size is valued at US$ million in 2021, while the US and Europe Viibryd (Vilazodone) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.
As for the Europe Viibryd (Vilazodone) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Viibryd (Vilazodone) include Allergan plc (AbbVie Inc.), Actavis Generics (Teva) and Clinical Data, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Viibryd (Vilazodone) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Viibryd (Vilazodone) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
1 Study Coverage
1.1 Viibryd (Vilazodone) Product Introduction
1.2 Market by Type
1.2.1 Global Viibryd (Vilazodone) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 10 mg
1.2.3 20 mg
1.2.4 40 mg
1.3 Market by Application
1.3.1 Global Viibryd (Vilazodone) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Major Depression
1.3.3 Anxiety
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Viibryd (Vilazodone) Sales Estimates and Forecasts 2017-2028
2.2 Global Viibryd (Vilazodone) Revenue Estimates and Forecasts 2017-2028
2.3 Global Viibryd (Vilazodone) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Viibryd (Vilazodone) Sales by Region
2.4.1 Global Viibryd (Vilazodone) Sales by Region (2017-2022)
2.4.2 Global Sales Viibryd (Vilazodone) by Region (2023-2028)
2.5 Global Viibryd (Vilazodone) Revenue by Region
2.5.1 Global Viibryd (Vilazodone) Revenue by Region (2017-2022)
2.5.2 Global Viibryd (Vilazodone) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Viibryd (Vilazodone) Sales by Manufacturers
3.1.1 Global Top Viibryd (Vilazodone) Manufacturers by Sales (2017-2022)
3.1.2 Global Viibryd (Vilazodone) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Viibryd (Vilazodone) in 2021
3.2 Global Viibryd (Vilazodone) Revenue by Manufacturers
3.2.1 Global Viibryd (Vilazodone) Revenue by Manufacturers (2017-2022)
3.2.2 Global Viibryd (Vilazodone) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Viibryd (Vilazodone) Revenue in 2021
3.3 Global Viibryd (Vilazodone) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Viibryd (Vilazodone) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Viibryd (Vilazodone) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Viibryd (Vilazodone) Sales by Type
4.1.1 Global Viibryd (Vilazodone) Historical Sales by Type (2017-2022)
4.1.2 Global Viibryd (Vilazodone) Forecasted Sales by Type (2023-2028)
4.1.3 Global Viibryd (Vilazodone) Sales Market Share by Type (2017-2028)
4.2 Global Viibryd (Vilazodone) Revenue by Type
4.2.1 Global Viibryd (Vilazodone) Historical Revenue by Type (2017-2022)
4.2.2 Global Viibryd (Vilazodone) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Viibryd (Vilazodone) Revenue Market Share by Type (2017-2028)
4.3 Global Viibryd (Vilazodone) Price by Type
4.3.1 Global Viibryd (Vilazodone) Price by Type (2017-2022)
4.3.2 Global Viibryd (Vilazodone) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Viibryd (Vilazodone) Sales by Application
5.1.1 Global Viibryd (Vilazodone) Historical Sales by Application (2017-2022)
5.1.2 Global Viibryd (Vilazodone) Forecasted Sales by Application (2023-2028)
5.1.3 Global Viibryd (Vilazodone) Sales Market Share by Application (2017-2028)
5.2 Global Viibryd (Vilazodone) Revenue by Application
5.2.1 Global Viibryd (Vilazodone) Historical Revenue by Application (2017-2022)
5.2.2 Global Viibryd (Vilazodone) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Viibryd (Vilazodone) Revenue Market Share by Application (2017-2028)
5.3 Global Viibryd (Vilazodone) Price by Application
5.3.1 Global Viibryd (Vilazodone) Price by Application (2017-2022)
5.3.2 Global Viibryd (Vilazodone) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Viibryd (Vilazodone) Market Size by Type
6.1.1 North America Viibryd (Vilazodone) Sales by Type (2017-2028)
6.1.2 North America Viibryd (Vilazodone) Revenue by Type (2017-2028)
6.2 North America Viibryd (Vilazodone) Market Size by Application
6.2.1 North America Viibryd (Vilazodone) Sales by Application (2017-2028)
6.2.2 North America Viibryd (Vilazodone) Revenue by Application (2017-2028)
6.3 North America Viibryd (Vilazodone) Market Size by Country
6.3.1 North America Viibryd (Vilazodone) Sales by Country (2017-2028)
6.3.2 North America Viibryd (Vilazodone) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Viibryd (Vilazodone) Market Size by Type
7.1.1 Europe Viibryd (Vilazodone) Sales by Type (2017-2028)
7.1.2 Europe Viibryd (Vilazodone) Revenue by Type (2017-2028)
7.2 Europe Viibryd (Vilazodone) Market Size by Application
7.2.1 Europe Viibryd (Vilazodone) Sales by Application (2017-2028)
7.2.2 Europe Viibryd (Vilazodone) Revenue by Application (2017-2028)
7.3 Europe Viibryd (Vilazodone) Market Size by Country
7.3.1 Europe Viibryd (Vilazodone) Sales by Country (2017-2028)
7.3.2 Europe Viibryd (Vilazodone) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Viibryd (Vilazodone) Market Size by Type
8.1.1 Asia Pacific Viibryd (Vilazodone) Sales by Type (2017-2028)
8.1.2 Asia Pacific Viibryd (Vilazodone) Revenue by Type (2017-2028)
8.2 Asia Pacific Viibryd (Vilazodone) Market Size by Application
8.2.1 Asia Pacific Viibryd (Vilazodone) Sales by Application (2017-2028)
8.2.2 Asia Pacific Viibryd (Vilazodone) Revenue by Application (2017-2028)
8.3 Asia Pacific Viibryd (Vilazodone) Market Size by Region
8.3.1 Asia Pacific Viibryd (Vilazodone) Sales by Region (2017-2028)
8.3.2 Asia Pacific Viibryd (Vilazodone) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Viibryd (Vilazodone) Market Size by Type
9.1.1 Latin America Viibryd (Vilazodone) Sales by Type (2017-2028)
9.1.2 Latin America Viibryd (Vilazodone) Revenue by Type (2017-2028)
9.2 Latin America Viibryd (Vilazodone) Market Size by Application
9.2.1 Latin America Viibryd (Vilazodone) Sales by Application (2017-2028)
9.2.2 Latin America Viibryd (Vilazodone) Revenue by Application (2017-2028)
9.3 Latin America Viibryd (Vilazodone) Market Size by Country
9.3.1 Latin America Viibryd (Vilazodone) Sales by Country (2017-2028)
9.3.2 Latin America Viibryd (Vilazodone) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Viibryd (Vilazodone) Market Size by Type
10.1.1 Middle East and Africa Viibryd (Vilazodone) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Viibryd (Vilazodone) Revenue by Type (2017-2028)
10.2 Middle East and Africa Viibryd (Vilazodone) Market Size by Application
10.2.1 Middle East and Africa Viibryd (Vilazodone) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Viibryd (Vilazodone) Revenue by Application (2017-2028)
10.3 Middle East and Africa Viibryd (Vilazodone) Market Size by Country
10.3.1 Middle East and Africa Viibryd (Vilazodone) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Viibryd (Vilazodone) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan plc (AbbVie Inc.)
11.1.1 Allergan plc (AbbVie Inc.) Corporation Information
11.1.2 Allergan plc (AbbVie Inc.) Overview
11.1.3 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan plc (AbbVie Inc.) Recent Developments
11.2 Actavis Generics (Teva)
11.2.1 Actavis Generics (Teva) Corporation Information
11.2.2 Actavis Generics (Teva) Overview
11.2.3 Actavis Generics (Teva) Viibryd (Vilazodone) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Actavis Generics (Teva) Viibryd (Vilazodone) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Actavis Generics (Teva) Recent Developments
11.3 Clinical Data, Inc.
11.3.1 Clinical Data, Inc. Corporation Information
11.3.2 Clinical Data, Inc. Overview
11.3.3 Clinical Data, Inc. Viibryd (Vilazodone) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Clinical Data, Inc. Viibryd (Vilazodone) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Clinical Data, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Viibryd (Vilazodone) Industry Chain Analysis
12.2 Viibryd (Vilazodone) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Viibryd (Vilazodone) Production Mode & Process
12.4 Viibryd (Vilazodone) Sales and Marketing
12.4.1 Viibryd (Vilazodone) Sales Channels
12.4.2 Viibryd (Vilazodone) Distributors
12.5 Viibryd (Vilazodone) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Viibryd (Vilazodone) Industry Trends
13.2 Viibryd (Vilazodone) Market Drivers
13.3 Viibryd (Vilazodone) Market Challenges
13.4 Viibryd (Vilazodone) Market Restraints
14 Key Findings in The Global Viibryd (Vilazodone) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Viibryd (Vilazodone) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 10 mg
Table 3. Major Manufacturers of 20 mg
Table 4. Major Manufacturers of 40 mg
Table 5. Global Viibryd (Vilazodone) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Viibryd (Vilazodone) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Viibryd (Vilazodone) Sales by Region (2017-2022) & (K Units)
Table 8. Global Viibryd (Vilazodone) Sales Market Share by Region (2017-2022)
Table 9. Global Viibryd (Vilazodone) Sales by Region (2023-2028) & (K Units)
Table 10. Global Viibryd (Vilazodone) Sales Market Share by Region (2023-2028)
Table 11. Global Viibryd (Vilazodone) Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Viibryd (Vilazodone) Revenue Market Share by Region (2017-2022)
Table 13. Global Viibryd (Vilazodone) Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Viibryd (Vilazodone) Revenue Market Share by Region (2023-2028)
Table 15. Global Viibryd (Vilazodone) Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Viibryd (Vilazodone) Sales Share by Manufacturers (2017-2022)
Table 17. Global Viibryd (Vilazodone) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Viibryd (Vilazodone) Revenue Share by Manufacturers (2017-2022)
Table 19. Viibryd (Vilazodone) Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Viibryd (Vilazodone) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Viibryd (Vilazodone) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viibryd (Vilazodone) as of 2021)
Table 22. Viibryd (Vilazodone) Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Viibryd (Vilazodone) Product Offered
Table 24. Date of Manufacturers Enter into Viibryd (Vilazodone) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Viibryd (Vilazodone) Sales by Type (2017-2022) & (K Units)
Table 27. Global Viibryd (Vilazodone) Sales by Type (2023-2028) & (K Units)
Table 28. Global Viibryd (Vilazodone) Sales Share by Type (2017-2022)
Table 29. Global Viibryd (Vilazodone) Sales Share by Type (2023-2028)
Table 30. Global Viibryd (Vilazodone) Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Viibryd (Vilazodone) Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Viibryd (Vilazodone) Revenue Share by Type (2017-2022)
Table 33. Global Viibryd (Vilazodone) Revenue Share by Type (2023-2028)
Table 34. Viibryd (Vilazodone) Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Viibryd (Vilazodone) Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Viibryd (Vilazodone) Sales by Application (2017-2022) & (K Units)
Table 37. Global Viibryd (Vilazodone) Sales by Application (2023-2028) & (K Units)
Table 38. Global Viibryd (Vilazodone) Sales Share by Application (2017-2022)
Table 39. Global Viibryd (Vilazodone) Sales Share by Application (2023-2028)
Table 40. Global Viibryd (Vilazodone) Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Viibryd (Vilazodone) Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Viibryd (Vilazodone) Revenue Share by Application (2017-2022)
Table 43. Global Viibryd (Vilazodone) Revenue Share by Application (2023-2028)
Table 44. Viibryd (Vilazodone) Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Viibryd (Vilazodone) Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Viibryd (Vilazodone) Sales by Type (2017-2022) & (K Units)
Table 47. North America Viibryd (Vilazodone) Sales by Type (2023-2028) & (K Units)
Table 48. North America Viibryd (Vilazodone) Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Viibryd (Vilazodone) Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Viibryd (Vilazodone) Sales by Application (2017-2022) & (K Units)
Table 51. North America Viibryd (Vilazodone) Sales by Application (2023-2028) & (K Units)
Table 52. North America Viibryd (Vilazodone) Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Viibryd (Vilazodone) Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Viibryd (Vilazodone) Sales by Country (2017-2022) & (K Units)
Table 55. North America Viibryd (Vilazodone) Sales by Country (2023-2028) & (K Units)
Table 56. North America Viibryd (Vilazodone) Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Viibryd (Vilazodone) Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Viibryd (Vilazodone) Sales by Type (2017-2022) & (K Units)
Table 59. Europe Viibryd (Vilazodone) Sales by Type (2023-2028) & (K Units)
Table 60. Europe Viibryd (Vilazodone) Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Viibryd (Vilazodone) Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Viibryd (Vilazodone) Sales by Application (2017-2022) & (K Units)
Table 63. Europe Viibryd (Vilazodone) Sales by Application (2023-2028) & (K Units)
Table 64. Europe Viibryd (Vilazodone) Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Viibryd (Vilazodone) Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Viibryd (Vilazodone) Sales by Country (2017-2022) & (K Units)
Table 67. Europe Viibryd (Vilazodone) Sales by Country (2023-2028) & (K Units)
Table 68. Europe Viibryd (Vilazodone) Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Viibryd (Vilazodone) Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Viibryd (Vilazodone) Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Viibryd (Vilazodone) Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Viibryd (Vilazodone) Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Viibryd (Vilazodone) Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Viibryd (Vilazodone) Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Viibryd (Vilazodone) Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Viibryd (Vilazodone) Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Viibryd (Vilazodone) Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Viibryd (Vilazodone) Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Viibryd (Vilazodone) Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Viibryd (Vilazodone) Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Viibryd (Vilazodone) Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Viibryd (Vilazodone) Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Viibryd (Vilazodone) Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Viibryd (Vilazodone) Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Viibryd (Vilazodone) Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Viibryd (Vilazodone) Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Viibryd (Vilazodone) Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Viibryd (Vilazodone) Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Viibryd (Vilazodone) Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Viibryd (Vilazodone) Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Viibryd (Vilazodone) Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Viibryd (Vilazodone) Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Viibryd (Vilazodone) Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Viibryd (Vilazodone) Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Viibryd (Vilazodone) Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Viibryd (Vilazodone) Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Viibryd (Vilazodone) Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Viibryd (Vilazodone) Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Viibryd (Vilazodone) Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Viibryd (Vilazodone) Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Viibryd (Vilazodone) Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Viibryd (Vilazodone) Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Viibryd (Vilazodone) Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Viibryd (Vilazodone) Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Viibryd (Vilazodone) Revenue by Country (2023-2028) & (US$ Million)
Table 106. Allergan plc (AbbVie Inc.) Corporation Information
Table 107. Allergan plc (AbbVie Inc.) Description and Major Businesses
Table 108. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Allergan plc (AbbVie Inc.) Recent Developments
Table 111. Actavis Generics (Teva) Corporation Information
Table 112. Actavis Generics (Teva) Description and Major Businesses
Table 113. Actavis Generics (Teva) Viibryd (Vilazodone) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Actavis Generics (Teva) Viibryd (Vilazodone) Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Actavis Generics (Teva) Recent Developments
Table 116. Clinical Data, Inc. Corporation Information
Table 117. Clinical Data, Inc. Description and Major Businesses
Table 118. Clinical Data, Inc. Viibryd (Vilazodone) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Clinical Data, Inc. Viibryd (Vilazodone) Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Clinical Data, Inc. Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Viibryd (Vilazodone) Distributors List
Table 124. Viibryd (Vilazodone) Customers List
Table 125. Viibryd (Vilazodone) Market Trends
Table 126. Viibryd (Vilazodone) Market Drivers
Table 127. Viibryd (Vilazodone) Market Challenges
Table 128. Viibryd (Vilazodone) Market Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Viibryd (Vilazodone) Product Picture
Figure 3. Global Viibryd (Vilazodone) Market Share by Type in 2021 & 2028
Figure 3. 10 mg Product Picture
Figure 4. 20 mg Product Picture
Figure 5. 40 mg Product Picture
Figure 6. Global Viibryd (Vilazodone) Market Share by Application in 2021 & 2028
Figure 7. Major Depression
Figure 8. Anxiety
Figure 9. Others
Figure 10. Viibryd (Vilazodone) Report Years Considered
Figure 11. Global Viibryd (Vilazodone) Sales 2017-2028 (K Units)
Figure 12. Global Viibryd (Vilazodone) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Viibryd (Vilazodone) Revenue 2017-2028 (US$ Million)
Figure 14. Global Viibryd (Vilazodone) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Viibryd (Vilazodone) Sales Market Share by Region (2017-2022)
Figure 16. Global Viibryd (Vilazodone) Sales Market Share by Region (2023-2028)
Figure 17. North America Viibryd (Vilazodone) Sales YoY (2017-2028) & (K Units)
Figure 18. North America Viibryd (Vilazodone) Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Viibryd (Vilazodone) Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Viibryd (Vilazodone) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Viibryd (Vilazodone) Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Viibryd (Vilazodone) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Viibryd (Vilazodone) Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Viibryd (Vilazodone) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Viibryd (Vilazodone) Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Viibryd (Vilazodone) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Viibryd (Vilazodone) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Viibryd (Vilazodone) in the World: Market Share by Viibryd (Vilazodone) Revenue in 2021
Figure 29. Global Viibryd (Vilazodone) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Viibryd (Vilazodone) Sales Market Share by Type (2017-2028)
Figure 31. Global Viibryd (Vilazodone) Revenue Market Share by Type (2017-2028)
Figure 32. Global Viibryd (Vilazodone) Sales Market Share by Application (2017-2028)
Figure 33. Global Viibryd (Vilazodone) Revenue Market Share by Application (2017-2028)
Figure 34. North America Viibryd (Vilazodone) Sales Market Share by Type (2017-2028)
Figure 35. North America Viibryd (Vilazodone) Revenue Market Share by Type (2017-2028)
Figure 36. North America Viibryd (Vilazodone) Sales Market Share by Application (2017-2028)
Figure 37. North America Viibryd (Vilazodone) Revenue Market Share by Application (2017-2028)
Figure 38. North America Viibryd (Vilazodone) Sales Share by Country (2017-2028)
Figure 39. North America Viibryd (Vilazodone) Revenue Share by Country (2017-2028)
Figure 40. U.S. Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Viibryd (Vilazodone) Sales Market Share by Type (2017-2028)
Figure 43. Europe Viibryd (Vilazodone) Revenue Market Share by Type (2017-2028)
Figure 44. Europe Viibryd (Vilazodone) Sales Market Share by Application (2017-2028)
Figure 45. Europe Viibryd (Vilazodone) Revenue Market Share by Application (2017-2028)
Figure 46. Europe Viibryd (Vilazodone) Sales Share by Country (2017-2028)
Figure 47. Europe Viibryd (Vilazodone) Revenue Share by Country (2017-2028)
Figure 48. Germany Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 49. France Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Viibryd (Vilazodone) Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Viibryd (Vilazodone) Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Viibryd (Vilazodone) Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Viibryd (Vilazodone) Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Viibryd (Vilazodone) Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Viibryd (Vilazodone) Revenue Share by Region (2017-2028)
Figure 59. China Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 62. India Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Viibryd (Vilazodone) Sales Market Share by Type (2017-2028)
Figure 70. Latin America Viibryd (Vilazodone) Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Viibryd (Vilazodone) Sales Market Share by Application (2017-2028)
Figure 72. Latin America Viibryd (Vilazodone) Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Viibryd (Vilazodone) Sales Share by Country (2017-2028)
Figure 74. Latin America Viibryd (Vilazodone) Revenue Share by Country (2017-2028)
Figure 75. Mexico Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Viibryd (Vilazodone) Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Viibryd (Vilazodone) Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Viibryd (Vilazodone) Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Viibryd (Vilazodone) Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Viibryd (Vilazodone) Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Viibryd (Vilazodone) Revenue Share by Country (2017-2028)
Figure 84. Turkey Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Viibryd (Vilazodone) Revenue (2017-2028) & (US$ Million)
Figure 87. Viibryd (Vilazodone) Value Chain
Figure 88. Viibryd (Vilazodone) Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
$4900
$7350
$9800
HAVE A QUERY?
OUR CUSTOMER
